NCT03904888 Conventional Versus Robot Assisted Laparoscopic Inguinal Hernia Repair
| NCT ID | NCT03904888 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Algemeen Ziekenhuis Maria Middelares |
| Condition | Inguinal Hernia |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2019-09-23 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2019-09-23 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluate the early postoperative course of patients undergoing laparoscopic inguinal hernia repair with either a conventional or a robot assisted approach and with or without the injection of the trocar wounds with a local anesthetic.
Eligibility Criteria
Inclusion Criteria: * adult patients presenting with a bilateral inguinal hernia planned for a minimal invasive laparoscopic repair Exclusion Criteria: * Age below 18 years * unilateral groin hernia repair * incarcerated hernias * open hernia repair * no informed consent * pregnant women * ASA score 4 or more * patient included in another study.
Contact & Investigator
Filip Muysoms, MD,PhD
PRINCIPAL INVESTIGATOR
Algemeen Ziekenhuis Maria Middelares
Frequently Asked Questions
Who can join the NCT03904888 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Inguinal Hernia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03904888 currently recruiting?
Yes, NCT03904888 is actively recruiting participants. Contact the research team at filip.muysoms@gmail.com for enrollment information.
Where is the NCT03904888 trial being conducted?
This trial is being conducted at Ghent, Belgium.
Who is sponsoring the NCT03904888 clinical trial?
NCT03904888 is sponsored by Algemeen Ziekenhuis Maria Middelares. The principal investigator is Filip Muysoms, MD,PhD at Algemeen Ziekenhuis Maria Middelares. The trial plans to enroll 200 participants.